全文获取类型
收费全文 | 17565篇 |
免费 | 1310篇 |
国内免费 | 62篇 |
专业分类
耳鼻咽喉 | 257篇 |
儿科学 | 622篇 |
妇产科学 | 414篇 |
基础医学 | 2047篇 |
口腔科学 | 269篇 |
临床医学 | 3177篇 |
内科学 | 2869篇 |
皮肤病学 | 157篇 |
神经病学 | 1430篇 |
特种医学 | 426篇 |
外国民族医学 | 2篇 |
外科学 | 1881篇 |
综合类 | 312篇 |
一般理论 | 32篇 |
预防医学 | 2303篇 |
眼科学 | 413篇 |
药学 | 1309篇 |
中国医学 | 48篇 |
肿瘤学 | 969篇 |
出版年
2023年 | 113篇 |
2022年 | 166篇 |
2021年 | 327篇 |
2020年 | 207篇 |
2019年 | 334篇 |
2018年 | 348篇 |
2017年 | 316篇 |
2016年 | 337篇 |
2015年 | 357篇 |
2014年 | 506篇 |
2013年 | 705篇 |
2012年 | 1107篇 |
2011年 | 1157篇 |
2010年 | 664篇 |
2009年 | 541篇 |
2008年 | 956篇 |
2007年 | 1056篇 |
2006年 | 964篇 |
2005年 | 936篇 |
2004年 | 935篇 |
2003年 | 847篇 |
2002年 | 802篇 |
2001年 | 370篇 |
2000年 | 378篇 |
1999年 | 339篇 |
1998年 | 202篇 |
1997年 | 180篇 |
1996年 | 166篇 |
1995年 | 141篇 |
1994年 | 134篇 |
1993年 | 114篇 |
1992年 | 250篇 |
1991年 | 291篇 |
1990年 | 213篇 |
1989年 | 200篇 |
1988年 | 158篇 |
1987年 | 181篇 |
1986年 | 169篇 |
1985年 | 190篇 |
1984年 | 135篇 |
1983年 | 130篇 |
1982年 | 79篇 |
1981年 | 84篇 |
1980年 | 74篇 |
1979年 | 117篇 |
1978年 | 90篇 |
1976年 | 81篇 |
1974年 | 77篇 |
1973年 | 76篇 |
1972年 | 77篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
Anucha Apisarnthanarak Somwang Danchaivijitr Thomas C Bailey Victoria J Fraser 《Infection control and hospital epidemiology》2006,27(4):416-420
The incidence and patterns of and factors associated with inappropriate antibiotic use were studied in a tertiary care center in Thailand. The incidence of inappropriate antibiotic use was 25%. Admission to the surgical department (adjusted odds ratio, 2.0; P=.02) and to the obstetrics and gynecology department (adjusted odds ratio, 2.0; P=.03) were associated with inappropriate antibiotic use, whereas consultation with an infectious diseases specialist was protective against inappropriate antibiotic use (adjusted odds ratio, 0.15; P=.01). 相似文献
42.
43.
Christopher G Goetz Stanley Fahn Pablo Martinez-Martin Werner Poewe Cristina Sampaio Glenn T Stebbins Matthew B Stern Barbara C Tilley Richard Dodel Bruno Dubois Robert Holloway Joseph Jankovic Jaime Kulisevsky Anthony E Lang Andrew Lees Sue Leurgans Peter A LeWitt David Nyenhuis C Warren Olanow Olivier Rascol Anette Schrag Jeanne A Teresi Jacobus J Van Hilten Nancy LaPelle 《Movement disorders》2007,22(1):41-47
This article presents the revision process, major innovations, and clinimetric testing program for the Movement Disorder Society (MDS)-sponsored revision of the Unified Parkinson's Disease Rating Scale (UPDRS), known as the MDS-UPDRS. The UPDRS is the most widely used scale for the clinical study of Parkinson's disease (PD). The MDS previously organized a critique of the UPDRS, which cited many strengths, but recommended revision of the scale to accommodate new advances and to resolve problematic areas. An MDS-UPDRS committee prepared the revision using the recommendations of the published critique of the scale. Subcommittees developed new material that was reviewed by the entire committee. A 1-day face-to-face committee meeting was organized to resolve areas of debate and to arrive at a working draft ready for clinimetric testing. The MDS-UPDRS retains the UPDRS structure of four parts with a total summed score, but the parts have been modified to provide a section that integrates nonmotor elements of PD: I, Nonmotor Experiences of Daily Living; II, Motor Experiences of Daily Living; III, Motor Examination; and IV, Motor Complications. All items have five response options with uniform anchors of 0 = normal, 1 = slight, 2 = mild, 3 = moderate, and 4 = severe. Several questions in Part I and all of Part II are written as a patient/caregiver questionnaire, so that the total rater time should remain approximately 30 minutes. Detailed instructions for testing and data acquisition accompany the MDS-UPDRS in order to increase uniform usage. Multiple language editions are planned. A three-part clinimetric program will provide testing of reliability, validity, and responsiveness to interventions. Although the MDS-UPDRS will not be published until it has successfully passed clinimetric testing, explanation of the process, key changes, and clinimetric programs allow clinicians and researchers to understand and participate in the revision process. 相似文献
44.
45.
46.
Clinically, phenol is used often as a neurolytic agent to treat pain and spasticity. The purpose of this study was to examine the time course of denervation and recovery in several hindlimb muscles following application of a 5% aqueous solution of phenol to the sciatic nerve. Phenol was applied to the sciatic nerve of adult female rats either by intraneural or perineural injection. Axonal degeneration was evident within the sciatic nerve 2 days following phenol application, although variable amounts of damage were observed. By 2 weeks, the soleus and tibialis anterior had atrophied to 63% and 51% of control. Reinnervation of hindlimb muscles occurred between 2 and 4 weeks following the nerve block. Following denervation, the soleus became slower in that all of the fibers expressed the slow myosin heavy chain (MHC). At 5 months, maximum tension of the soleus was 74% of control and the muscle consisted of more fast fibers on average, some of which expressed IIx MHC. These data suggest that 5% phenol causes an injury to the nerve that is more severe than a crush injury, and that reinnervation of denervated muscles may be by motoneurons other than those that originally innervated the muscles. © 1996 John Wiley & Sons, Inc. 相似文献
47.
R N Dickerson R C Fried P M Bailey T P Stein J L Mullen G P Buzby 《The Journal of surgical research》1990,48(1):38-41
Pharmacologic therapy designed to block adrenergic activity or alter hormonal milieu may modulate energy and protein metabolism in stress. The metabolic effects of propranolol (beta adrenergic receptor blocker) in sepsis was investigated in 22 well-nourished rats that underwent superior vena caval cannulation, cecal ligation, and puncture. Animals were randomly assigned to receive either a continuous infusion of 0.7 mg/day of propranolol combined with parenteral nutrition (n = 11) or parenteral nutrition alone (n = 11). Both groups received isocaloric, isonitrogenous, isovolemic, parenteral nutrition post-operatively for 24 hr. Nitrogen balance was better for the propranolol group than for the control group (+743 +/- 84 mg/kg/day versus +300 +/- 63 mg/kg/day, respectively, P less than 0.05). A significant difference between the pharmacologic therapy and control groups was noted for urinary 3-methylhistidine excretion versus control (0.99 +/- 0.08 micrograms/kg/day versus 7.5 +/- 0.37 micrograms/kg/day, respectively, P less than 0.01). Measured energy expenditure was similar for both pharmacologic therapy and control groups (149 +/- 20 kcal/kg/day versus 134 +/- 11 kcal/kg/day, respectively, P = N.S.). No statistically significant difference was demonstrated for 24-hr survival between propranolol and control groups (73 and 64%, respectively). Continuous, low-dose propranolol promotes nitrogen retention and decreases 3-methylhistidine excretion without altering energy expenditure in parenterally fed septic rats. 相似文献
48.
49.
Mr. Richard M. Reichley B.S. Pharm. Dr. David J. Ritchie Pharm.D. Dr. Thomas C. Bailey M.D. 《Pharmacotherapy》1995,15(5):625-630
Predicted gentamicin elimination rate constants (kels) using creatinine clearance (C1cr) estimates from seven equations were compared with kels calculated from steady-state serum gentamicin concentrations in 186 hospitalized patients. In predicting kel, the equations varied significantly in precision (mean absolute percentage error), and were particularly imprecise among patients with serum creatinine values of 71 μmol/L or less. Significant differences in bias (mean prediction error) were also observed. All equations using serum creatinine as an element showed improved precision, and most showed reduced bias when a minimum value of 71 μmol/L was used. The Cockcroft-Gault normalized to 72 kg and the Hull equations are among the simplest to calculate and, when using a minimum serum creatinine of 71 μmol/L, had significantly greater precision and less bias than several of the equations. We recommend one of these two methods for predicting gentamicin kel in patients with low serum creatinine values. 相似文献
50.